Summary The 50% survival time for low grade astrocytomas is 50 months and for high grade astrocytomas it is 13 months, underlining the need for new therapies. Several reports show that in vivo histamine antagonists cause retardation of tumour growth in some animal models and prolonged survival in cancer patients. Therefore we have tested the growth modulating effects of histamine and histamine antagonists on human glioma cultures.
The prognosis for patients with glioma is poor. Around 1950 the time for survival to fall to 50% was 46 months for low grade and 9 months for high grade astrocytomas . These discomforting figures have shown only a very limited improvement (Nazarro & Neuwelt, 1990) ; 40 years later 50% survival is 50 and 13 months for low grade and high grade astrocytomas respectively (Daumas-Duport et al., 1988) , which is mostly due to changes in surgical technique and anaesthetics. While radiotherapy has some minor effect on the duration of survival, cures have not been reported (Leibel & Sheline, 1987) . Chemotherapy is as yet ineffective in the treatment of astrocytoma (Kornblith & Walker, 1988) . Although prognosis in oligodendrogliomas is slightly better (Smith et al., 1983) , chemotherapy and irradiation likewise have no, or a very limited effect (Leibel & Sheline, 1987; Kornblith & Walker, 1988) . New approaches in glioma therapy are therefore needed. We have examined the proliferation modifying effects of histamine, the Hlreceptor antagonist pyrilamine and the H2-receptor antagonist cimetidine on glioma cell lines in order to select a possible candidate for in vivo tumour growth suppression. Histamine can act, at least in part, as a growth factor, as the rate of tissues proliferation in wound repair, embryogenesis, and malignant growth is related to the level of histamine production (Kahlson & Rosengren, 1968) . Locally synthesised histamine favours tumour cell growth both by autocrine stimulation and by activating T-suppressor cell function (Bartholeyns & Fozard, 1985) .
Histamine can exert its action through binding at Hr-or H2-receptors. Specific agonists and antagonists for both receptors are useful tools in research concerning the growth stimulating action of histamine. Thus, it has been reported that tumour growth can be stimulated by histamine alone or combined with the HI antagonist mepyramide, or by the histamine H2 agonist dimiprit in experimental in vivo models (Tutton & Barkla, 1978; Burtin et al., 1982) . Histamine H2 antagonists (cimetidine or metiamide) inhibit tumour cell growth (Tutton & Barkla, 1978; Tutton & Steel, 1979; Burtin et al., 1982; Tutton & Barkla, 1987) . Apparently, histamine favours in vivo tumour cell proliferation via the H2-receptors.
Cimetidine therapy given for epigastric distress in two patients with lung carcinoma caused tumour regression in the absence of any antitumour therapy (Armitage & Sidner, 1979) . In addition, cimetidine therapy for epigastric complaints in patients with gastric cancer induced a prolonged survival (Scotcher et al., 1981) . Patients with advanced cancers predominantly of the digestive tract survived longer after treatment with cimetidine alone (Tonnesen et al., 1988) or cimetidine combined with histamine (Burtin et al., 1988) . These findings offer a rationale for our study of the growth modulating effects of histamine and histamine antagonists on glioma cell lines.
Materials and methods
Tumours, cell lines, and culture system Twelve cerebral glial tumours were obtained at surgery. The tumours were put into tissue culture as soon as possible, usually within 2 h after surgical removal. To obtain a cell suspension, the tumours were minced and digested with an enzyme solution containing collagenase type I (0.05% w/v; Worthington), dispase grade II (1.25 U ml-', Boehringer Mannheim) and hyaluronidase (0.1% w/v; Boehringer) dissolved in Dulbecco's Modified Eagles Medium (DMEM) supplemented with 10% heat inactivated Fetal Calf Serum (FCS; Gibco, Paisley) (Pleasure et al., 1986) . After 2 h of digestion at 37°C with continuous gentle agitation, the resultant cell suspension was washed and cultured in 25 cm2 plastic culture flasks (Costar, Cambridge, MA, USA) at 37°C in 5% CO2 in air. Solid tumours required an overnight incubation in an 1:20 diluted enzyme solution (diluted in DMEM with 10% FCS). The emerging cell lines were marked with a lab identifier (PU , Table I ), which is omitted in the text, and a individual code.
Four continuous glioma cell lines were used in order to confirm the glioma-specificity of the effects observed in the (Ponten & Macintyre, 1968) were purchased from the ATCC; the U343MG line was a gift from C.-H. Heldin (Nister et al., 1986) . Cells were cultured in DMEM supplemented with penicillin (102 U ml'; Northumbria Biologicals, Cramlington), streptomycin (102 ,jg ml-'; Northhumbria), neomycin (0.1 mg ml-'; Gibco, Chagrin Falls, OH, USA). In the regular culture system 10% heat inactivated FCS was added.
To passage the cultures, the adhering cells were dissociated by incubating them for 2 min with 0.1% trypsin (Sigma Chemicals, St. Louis, MO USA) dissolved in a Ca2", Mg2+ free medium, and split in a 1:4 ratio.
Characterisation ofprimary cultures
For the characterisation of primary cultures we relied on the morphological criteria for identification of cultures derived from gliomas as described by Ponten (Ponten & Macintyre, 1968) and Freshney (1980) . If a sufficient number of cells was available, the glioma tumour cultures were characterised with immuno-staining for glial fibrillary acidic protein (GFAP). For this purpose, cells were cultured in 8-chamber Lab-teks (Nunc, Naperville, IL USA), fixed in acetone, and incubated with antibodies to GFAP (Eurodiagnostics Apeldoorn, The Netherlands). Bound antibody was visualised using a biotinylated second antibody (goat anti-rabbit from Vector Laboratories, Burlingame, CA USA) and the avidin-biotinhorseradish peroxidase complex method (ABC, Vector) (Hsu et al., 1989) . As a chromogenic substrate 3',3'-diaminobenzidine (Sigma) was used.
The (Jordana et al., 1988; Tilly et al., 1990) . In the experiments we used 1% FCS (with some exceptions, as indicated in the results) to obtain low level proliferation. Under these conditions both stimulation and inhibition of proliferation could be measured relative to control proliferation (1% FCS alone). Some experiments were repeated with 1% pooled human AB serum. The influence of low histamine concentration on glioma cell proliferation was also tested without serum. In all low serum experiments the culture medium was enriched with transferrin (10 tgml-'; Sigma), sodium pyruvate (1 mM; Sigma), sodium selenite (30 pM; Sigma), 3,3',5-triiodo-L-thyronine (7.5 nM; Sigma), MEM Non Essential Amino Acids (1:100, Sigma), and BME vitamins (mixture; 1:100, Sigma). Growth curves were constructed by recording cell density as a measure of cell proliferation at 2-3 day intervals within 10-12 days after seeding (e.g. at days 1, 3, 6, 8 and 10) . For this purpose we used a protocol adapted from Pelletier (Pelletier et al., 1988) . Briefly, glutaraldehyde (25%) was added to the wells and washed away after 20 min with warm tapwater (30°C); then methylene blue (0.05%) was added for 15 min and washed away with tapwater at 30°C; the bound dye was extracted from the cells with 0.33 M HCI and the absorbance of the dye in the wells was recorded in a Titertek multiscan spectrophotometer at 620 nm. This method gave reliable data in growth rate studies using adhering cells (Pelletier et al., 1988) . In our system, this method gave a linear correlation for the number of seeded cells and the extinction for 1,500-65,000 cells per well (corresponding extinction values 0.020-1.100). The number of population doublings (PD) from the first to the last measure point (day a -day n) was calculated from extinction values measured on these days (Ea and En) using the formula: PDday(a n) = 2log(En/ Ea). Results 
Characterisation of cell lines
The second column of Table I shows the original histopathological diagnosis of the cultured tumours, named in the first column, classified according to Kernohan et al. (1949) . The doubling time of the primary cell lines was 18-73 h under optimal conditions (10% FCS; column 4). This growth rate is given for early passages (<P5). Three out of 12 primary cell lines seemed to be immortalised, as they could be passaged more than 20 times. The fact that 4/12 of our cultures died after a relatively low number of passages is in line with the observation that approximately 50% of human glioma cultures do not establish (Bigner & Mark, 1984) .
The primary cultures, observed by phase-contrast microscopy, showed disoriented growth and loss of contact inhibition. The morphology of the individual cells varied between cultures and included irregularity within and between the different cases, haphazard orientation and postconfluential growth. All cells showed a clearly visible cell-body with a rim of cytoplasm around the nucleus, and in most cultures cells had a multipolar appearance, caused by multiple irregular cytoplasmic processes. In our series we found a variation in the aspect of these processes from relatively compact to very long and slender (Figure la and b ). Figure lb also shows broadening and flattening of some processes, suggesting a polarity that may reflect migratory activity of the cell (Forsby et al., 1986) . Figure lc shows the poorly differentiated, fibroblast-like aspect of cell line G47.
When stained for the expression of GFAP (Table I, 6th column), all tested cell lines showed positive staining. Staining intensities varied from intense (3/8 cases) to moderate (4/8) and weak (1/8).
DNA measurements were carried out on six cell lines, using fluorescent flow cytometry. Chromosome analysis was successfully carried out on four cell lines, G47, G223, G226 and G233 (Table I , last column).
Effects of histamine and histamine antagonists on proliferation Cells were cultured at suboptimal conditions in order to be able to measure positive and negative effects of the added factors on proliferation. In most cultures this was realised using 1% serum. However, cell line U138MG and U373MG were tested at 0.5% and 0.25% serum, respectively, because of high proliferation rate at 1% serum. Figure 3a shows an example of the growth curves in one such an experiment. The cell line G15 showed maximal proliferation with 10% FCS, giving a population doubling time of 44 h in the middle log phase, which is transported to Table I . The effects of histamine, cimetidine and pyrilamine were measured during logarithmic growth (day 3-10) in 1% FCS. The differences in number of population doublings between the growth curves and the control growth curve (1% FCS) were calculated and transported to Figure 3b and Table II . In this table, the results of the stimulation/inhibition experiments are summarised. Cell lines G233/a and G233/b are considered as separate cultures. The addition of 0.2 mM histamine induced significant stimulation of proliferation in primary cell lines both tested with 1% FCS (3/9 cases) or 1% AB serum (2/3 cases), and also in continuous cell lines (2/4 cases tested with FCS and in 1/4 tested with AB serum). Inhibition of proliferation was found in one case (U87MG). Addition of 0.2 tIM histamine induced significant stimulation of proliferation in 0/2 continuous cell lines and in 2/2 primary cell lines, but only when tested with AB serum. Without serum addition, 0.2 jSM histamine induced significant stimulation in 2/3 primary and in 1/1 continuous cell lines. In summary, proliferation of 2/4 continuous cell lines and of 9/13 primary cell lines was stimulated with histamine in one or the other tested condition, inhibition occurred in 1/4 continuous cell lines.
The addition of 1 mM cimetidine induced significant inhibition of proliferation in 2/4 continous cell lines when tested with FCS and in 3/4 cases lines when tested with AB serum. The proliferation of the primary cell lines was inhibited significantly with 1 mM cimetidine in 4/13 cases when tested with FCS and in 4/5 cases when tested with AB serum, making a total of 6/13 primary cell lines that were reactive to cimetidine.
The effect of the addition of 0.1 mM pyrilamine was variable. The combined results of FCS and AB serum show that inhibition was found in 3/4 continuous cell lines and in 2/8 primary cell lines, while 3/8 primary cell lines were stimulated.
Because of the consistent inhibiting effect of cimetidine, we tested the effect of lower concentrations in two responsive continuous cell lines and two responsive primary cell lines. Figure 4 shows that maximal inhibition is obtained at 1 mM cimetidine in all four cases and that there was a doseresponse relation in two cell lines (U138MG and G226). G15 showed significant inhibition even at 1 tLM cimetidine. 
Specificity of the measured inhibition
In order to test the specificity of the observed inhibition with cimetidine and pyrilamine, the effect of addition of 0.2 mm histamine to the cimetidine-inhibited culture was tested in one continuous cell line (U138MG) and in two primary cell lines (GI 5 and G61 1). The same test was performed in the pyrilamine-inhibited culture of one continuous cell line (U138MG) and one primary cell line (G47). Figure 5a shows that histamine addition significantly reversed the cimetidineinduced effect in U138MG and in G611. Figure Sb shows that pyrilamine-induced inhibition was significantly reduced in both cases.
Correlation of cimetidine-induced growth inhibition with the maximal growth rate The observations with the primary cell lines suggested an inverse correlation between cimetidine responsiveness and the maximal growth rate of a given cell line, observed with 10% FCS addition. This was confirmed by calculating the linear regression between these two parameters ( Figure 6 ). The correlation coefficient was -0.73 with a chance probability Serum was added in a concentration of 1%, except in U138MG and U373MG, which were tested at 0.5% and 0.25% serum, respectively. (Ito et al., 1989) .
Cytogenic studies on cell lines G47 and G223 revealed complex karyotypes with structural and numerical variation. Both of these lines were derived from high grade tumours. The association between complex karyotypic changes and high malignancy in brain tumours has been reported recently by Kimmel et al. (1992) . Of particular note is the presence of structural abnormalities involving the short arm of chromosome 9 in cell lines G47 and G223. Kimmel et al. (1992) also demonstrated that aberrations of 9p appear to be continued to brain tumours of high malignancy. Molecular studies using a range of probes for this region of sent an important step in the progression of these tumours (Olufunmilayo et al., 1992) . Loss of heterozygosity for genetic loci on the long arm of chromosome 10 also occurs frequently in gliomas (Rasheed et al., 1992) ; cell line G47 had a deletion of region 10ql2q24. The other chromosomal abnormalities found in these two cell lines are typical of these reported for glioma (Jenkins et al., 1989; Ransom et al., 1992) . Cytogenic studies were carried out twice on cell line G233. Line G233/a had been maintained serially in tissue culture from the original tumour biopsy. Line G233/b was derived from cells cultured after storage in liquid nitrogen at a very early stage of growth of the original tumour. In both lines G233/a and G233/b abnormal clones were identified, but with different chromosomal abnormalities within the diploid range. This suggests either that the observed karyotype changes are a culturing artefact or that they represent a selection of the original tumour cell population. Line G233/b had trisomy 7 which had been reported as a culturing artefact in normal brain cells (Heim et al., 1989) , but is also one of the more common changes found in gliomas (Bigner et al., 1988; Arnoldus et al., 1991) . The normal karyotypes of culture G226 and the main population of culture G233/a may indicate that these cultures originated from gliomas with a comparatively homogeneous population of near-diploid cells, which form the majority of gliomas (Bigner & Mark, 1984) .
The finding with flow cytometry of an aneuploid peak in all four tested high-grade gliomas and diploid peak in one high-grade and one low-grade glioma agrees with the distribution found by others (Onda et al., 1988; Spaar & Spaar, 1990) .
Morphology and GFAP staining indicate that the used method was successul in establishing primary glioma cell cultures. As mentioned above, karyotyping and flow cytometry suggest a distribution and specificity of anomalies corresponding with those found for gliomas. Another argument for the glioma nature of our cultures is that the results of the continuous cell lines parallel those of the primary cell lines. On the other hand, it should be considered that it is most likely that even the early passage populations represent a selection of the original tumour heterogeneity (Shapiro et al., 1981) . In addition the findings with cytogenetic and flow cytometric studies in the near-diploid range may be of nontumorous origin, and aneuploid findings may be generated in vitro, as we did not make direct preparations in order to identify original tumour characteristics (Shapiro et al., 1981; Onda et al., 1988) .
Sensitivity to histamine and histamine antagonists We could detect significant histamine-induced stimulation of proliferation in 12/16 tested glioma cell lines. This effect was found both in the continuous and in the primary cell lines. The differences that were found under the various test conditions (FCS, AB-serum, no serum) reflect differences in proliferation modulating capacity of the sera used. A growth stimulating effect of histamine has been implicated in other in vitro systems. Stimulatory activity via HI-receptors was found to occur in HeLa and A431 human carcinoma cells and A875 human melanoma cells (Tilly et al., 1990) ; and in normal human lung fibroblasts (Jordana et al., 1988) , normal canine airway smooth muscle cells (Panetteiri et al., 1990) , normal rat astrocytes (Rodriguez et al., 1989) and normal murine haematopoietic stem cells via the H2-receptors (Schneider et al., 1990) .
Cimetidine significantly inhibits cell proliferation in the majority of cell lines in the present study. This indicates the dependence of proliferation of these cell lines on stimulation of the H2-receptor. In three cell lines that showed no response to cimetidine in the presence of FCS, a significant inhibition was found in the presence of AB serum. This confirms the relative importance of histamine stimulation for cells cultured with AB serum. At low serum concentrations pyrilamine induced significant inhibition in 5/11 tested cell lines and stimulation in 2/11 cell lines. Inhibition of cell proliferation was also found in HN-1 human squamous carcinomas cells (Bijman et al., 1987) and normal human skin fibroblasts via HI-receptors (Johnson & Johnson, 1990) .
Three observations indicated that histamine antagonists induced a specific inhibition of proliferation and no nonspecific cytotoxic effect. First, there was a cell line specific sensitivity to the addition of cimetidine or pyrilamine as these factors could not inhibit proliferation in all cell lines. Second, the cimetidine-induced inhibition of proliferation obtained at low FCS concentration was inversely correlated with the maximal growth rate observed at 10% FCS (Figure 6 ), suggesting a decreasing importance of stimulation of the H2-receptor with increasing growth rate. Fast growing cell lines may have accumulated more mutations that make them sensitive to multiple growth stimuli (Den Otter et al., 1990 ) and thereby less depending on each separate stimulus, in casu histamine. Third, the observed histamine antagonist-induced inhibitions were reversed in some cell lines. The effects of histamine and its antagonists were not related to histology or classification of the original tumour.
Importance of histamine and histamine antagonists In five cell lines, addition of histamine in a concentration approaching the whole blood level (0.2 l4M) could stimulate proliferation. In two cell lines (U 138MG and U373MG), addition of 0.2 mM histamine was more effective than 0.2 JM. In this respect it is noteworthy that within a tumour the histamine level can rise due to local production (Ahlstrom et al., 1966; Bartholeyns & Fozard, 1985; Johnston, 1967; Kahlson et al., 1963; Mackay et al., 1960) . This implicates that even in vivo cells with low sensitivity to histamine may be stimulated to proliferate by this factor. Another implication of the histamine-forming capacity of tumour cells is that autocrine stimulation of glioma cell proliferation may be involved. Therefore, the histamine antagonist-induced inhibition of proliferation may reflect interference with stimulation by nascent histamine rather than with stimulation by serumderived histamine.
Our experiments indicate that both H2-and HI-receptors can be involved in the proliferation of glioma cells. Both receptors can be active on the same cell, as is illustrated by the histamine-induced vasodilatation, where both Hl-and H2-receptors are active in the relaxation of smooth muscle cells of small vessels (Douglas, 1985) . An alternative explanation is that in the glial tumours and the cultures that were derived from these tumours, two different cell populations were present, one bearing HI-receptors and the other bearing H2-receptors. In a cultured glial tumour several subpopulations can be present (Westermark et al., 1985; Shapiro et al., 1981) .
Cimetidine-induced inhibition was most prominent at a high concentration, that would be toxic in vivo. However, in the physiological situation, cell proliferation is regulated by the concerted action of balanced concentrations of various growth factors with stimulating and inhibiting actions (Sporn & Roberts, 1985; . The in vitro system lacks this delicate balance of stimuli. Therefore the impact of a lower concentration of a histamine receptor-blocking agent may be more prominent in vivo. This is supported by the obtained in vivo tumour growth-inhibiting effect of non-toxic concentrations of H2-receptor antagonists as mentioned in the Introduction. A particular problem concerning in vivo application of a water-soluble drug like cimetidine in the brain is the bloodbrain barrier. However, this barrier has been reported to be non-functional in nearly all tumours (Wolff & Boker, 1989) , or at least to a high extent in different gliomas or in different regions of a tumour (Shapiro & Shapiro, 1986) . This is due to ultrastructural changes like interendothelial junction abnormalities and fenestrations in tumour vessel walls, leading to increased permeability (Stewart et al., 1985) .
As noticed, subculturing human gliomas induces selection. Nevertheless, the high proportion of cultures that was reactive to histamine and its antagonists suggests a widespread sensitivity.
Conclusions
We conclude that histamine can be a potent growth stimulating factor for cell cultures that originate from human glial tumours. The H2-receptor was involved more consistently in this growth stimulation than the HI-receptor, and blocking the H2-receptor induced growth inhibition in high proportion of the cultures. In vivo, histamine H2-receptor antagonists can prolong survival in hosts bearing various human and animal tumours. Therefore, H2-receptor antagonists are potential candidates for the postsurgical treatment of glioma patients, depending on the extent of breakdown of the blood-brain barrier in the tumour.
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